Drug Use Investigation of Jzoloft.

Viatris

Status: Completed

Conditions: Panic Disorder; Depression

Treatments: Drug: Sertraline hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT00605865

A0501090

Details and patient eligibility

About

The objective of this surveillance is to collect information about 1) adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

Full description

All the patients whom an investigator prescribes the first Sertraline hydrochloride should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 2,272 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients need to be taking Sertraline hydrochloride in order to be enrolled in the surveillance.

Exclusion criteria

Patients not taking Sertraline hydrochloride.

Trial design

2,272 participants in 1 patient group

Sertraline hydrochloride.

Description:

Patients taking Sertraline hydrochloride.

Treatment:

Drug: Sertraline hydrochloride